Mechanistic and pharmacological issues of aspirin as an anticancer agent.

Mechanistic and pharmacological issues of aspirin as an anticancer agent.

Item
http://www.wikidata.org/entity/Q37277350
Toll-like receptors and cancer, particularly oral squamous cell carcinoma.Apoptotic effects of two COX-2 inhibitors on breast adenocarcinoma cells through COX-2 independent pathway.Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways.NSAIDs: learning new tricks from old drugsRole of platelets in inflammation and cancer: novel therapeutic strategies.The aspirin metabolite salicylate inhibits lysine acetyltransferases and MUC1 induced epithelial to mesenchymal transition.Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin.Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study.Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling.Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action.A Temporal Examination of Platelet Counts as a Predictor of Prognosis in Lung, Prostate, and Colon Cancer Patients.Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
P2860

Mechanistic and pharmacological issues of aspirin as an anticancer agent.

Item
http://www.wikidata.org/entity/Q37277350
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanistic and pharmacological issues of aspirin as an anticancer agent.
@en
Mechanistic and pharmacological issues of aspirin as an anticancer agent.
@nl
type
label
Mechanistic and pharmacological issues of aspirin as an anticancer agent.
@en
Mechanistic and pharmacological issues of aspirin as an anticancer agent.
@nl
prefLabel
Mechanistic and pharmacological issues of aspirin as an anticancer agent.
@en
Mechanistic and pharmacological issues of aspirin as an anticancer agent.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Mechanistic and pharmacological issues of aspirin as an anticancer agent.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932